Document Detail


Endoscopic removal of metallic airway stents.
MedLine Citation:
PMID:  15947327     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Complications of metallic airway stents include granulation tissue formation, fracture of struts, migration, and mucous plugging. When these complications result in airway injury or obstruction, it may become necessary to remove the stent. There have been few reports detailing techniques and complications associated with endoscopic removal of metallic airway stents. We report our experience with endoscopic removal of 30 such stents over a 3-year period. METHODS: We conducted a retrospective review of 25 patients who underwent endoscopic stent removal from March 2001 to April 2004. The patients ranged in age from 17 to 80 years (mean, 56.3 years). There were 10 male and 15 female patients. The stents had been placed for nonmalignant disease in 20 patients (80%) and malignant disease in 5 patients (20%). All procedures were done under general anesthesia with a rigid bronchoscope. Special attention was focused on the technique of stent removal and postoperative complications. RESULTS: Thirty metallic airway stents were successfully removed from 25 consecutive patients over a 3-year period. The basic method of removal involved the steady application of traction to the stent with alligator forceps. In all cases, an instrument such as the barrel of the rigid bronchoscope or a Jackson dilator was employed to help separate the stent from the airway wall before removal was attempted. In some instances, the airway wall was pretreated with thermal energy prior to stent removal. Complications were as follows: retained stent pieces (n = 7), mucosal tear with bleeding (n = 4), re-obstruction requiring temporary silicone stent placement (n = 14), need for postoperative mechanical ventilation (n = 6), and tension pneumothorax (n = 1). CONCLUSIONS: Although metallic stents may be safely removed endoscopically, complications are common and must be anticipated. Other investigators have described airway obstruction and death as a result of attempted stent removal. Placement and removal of metallic airway stents should only be performed at centers that are prepared to deal with the potentially life-threatening complications.
Authors:
William Lunn; David Feller-Kopman; Momen Wahidi; Simon Ashiku; Robert Thurer; Armin Ernst
Related Documents :
507297 - Sepsis in the management of complicated biliary disorders.
16995447 - Effect of percutaneous biliary drainage on serum levels of tumor markers in patients wi...
18266047 - Xanthogranulomatous inflammatory strictures of extrahepatic biliary tract: presentation...
15206487 - Palliative treatment for malignant jaundice: endoscopic vs surgical approach.
19171277 - Arthroscopic findings following traumatic hip dislocation in 14 professional athletes.
22480557 - Anesthetic management of a patient diagnosed with cadasil (cerebral arteriopathy, autos...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Chest     Volume:  127     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-06-10     Completed Date:  2005-07-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2106-12     Citation Subset:  AIM; IM    
Affiliation:
Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA 02215, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Airway Obstruction / diagnosis,  mortality,  therapy*
Bronchoscopy / adverse effects,  methods*
Coated Materials, Biocompatible
Device Removal / adverse effects,  methods*
Equipment Design
Equipment Safety
Female
Follow-Up Studies
Foreign-Body Migration / therapy*
Humans
Male
Metals
Middle Aged
Risk Assessment
Stents / adverse effects*
Survival Rate
Treatment Outcome
Chemical
Reg. No./Substance:
0/Coated Materials, Biocompatible; 0/Metals

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thoracentesis in patients with hematologic malignancy: yield and safety.
Next Document:  Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemo...